RESOURCES

News.

Announcements, awards, partnerships and press coverage — the record of what has actually happened. For analysis of regulation and disclosure practice, start with the blog.

Latest TrialAssure news

All news →
TrialAssure to Lead Hands-On Clinical Document Anonymisation Workshop at PHUSE EU Connect 2026 Interactive session in Glasgow will help sponsors and CROs navigate EU Clinical Trials Regulation disclosure requirements and make defensible anonymisation decisions GLASGOW, United Kingdom (October 22, 2026) – TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced today that Zach Weingarden (Director of AI Technology and Applications) and James Greene (Executive Leader, Growth & Partnerships) will lead an interactive, hands-on workshop at PHUSE EU Connect 2026 in Glasgow, United Kingdom. The workshop, titled “Redact, Protect, Disclose: A Practical Workshop on Clinical Document Anonymisation under EU CTR,” will take place on Monday, November 16, from 16:00 to 17:30 GMT in Room M2-4. With EU Clinical Trials Regulation (EU CTR) No 536/2014 fully implemented and the transition from the previous Clinical Trials Directive complete, sponsors and contract research organizations (CROs) face increasingly complex decisions about protecting sensitive information in documents intended for publication through the Clinical Trials Information System (CTIS). The challenge requires balancing patient privacy, commercially confidential information (CCI) and the public's need for meaningful clinical trial information. Excessive redaction can diminish the value of published documents, and insufficient anonymisation can expose sensitive information. “Clinical document anonymisation requires judgment, particularly when teams must balance transparency with the protection of sensitive information,” said Greene. “We designed this workshop to give participants an opportunity to work through realistic scenarios, compare their decisions with other professionals and develop approaches they can apply within their own organizations.” What participants will gain from attending The 90-minute workshop will place participants into small groups to evaluate realistic clinical document scenarios, including protocol excerpts, clinical study reports (CSRs) and patient narratives. Participants will be challenged to: ● Identify personal data and CCI requiring protection. ● Apply relevant regulatory guidance to practical anonymisation decisions. ● Evaluate the consequences of over-redaction and under-redaction. ● Compare interpretations and defend their decisions through group discussion. ● Develop practical decision-making frameworks for future disclosure activities. The session will draw on TrialAssure's experience supporting clinical document anonymisation across pharmaceutical and CRO programs. The company's ANONYMIZE® technology supports risk-based anonymisation and redaction across clinical documents, datasets and images, helping organizations balance privacy protection with the utility of disclosed information.

Latest ·

TrialAssure to Lead Hands-On Clinical Document Anonymisation Workshop at PHUSE EU Connect 2026

Interactive session in Glasgow will help sponsors and CROs navigate EU Clinical Trials Regulation disclosure requirements and make defensible anonymisation decisions GLASGOW, United Kingdom (October 22, 2026) – TrialAssure, a leading technology provider advancing…

Read the release →

2026

TrialAssure Establishes Physical Presence in The Netherlands to Advance Clinical Trial Transparency and Data Sharing Across Europe

2025

TrialAssure Officially Granted New Patent for Date Offset Anonymization Technology by U.S. Patent and Trademark OfficeRespected Data Science Industry Leader Chris Hurley Joins TrialAssure Advisory Leadership Team to Strengthen Data Strategy and InnovationTrialAssure Introduces Enhanced Architectural Techniques to Improve Accuracy, Visibility, Traceability, and Control Across its AI Platform for Pharma and BiotechNew Webinar Announced on Stronger Clinical Document Authoring Workflows with Certara & TrialAssureTrialAssure’s Zach Weingarden Joins Other Pharmaceutical Industry Leaders to Present on the Future of AI in Drug Development at RAPS Convergence 2025TrialAssure Enhances REGISTRY Platform with AI-Powered Protocol Parsing to Streamline Global Clinical Trial Registration

2024

Generative AI Medical Writing Tool for the Pharmaceutical and Biotechnology Industries From TrialAssure Gets a Major Upgrade to Make Scientific Document Creation EasierTrialAssure Wins Prestigious MichBusiness Triple Trusted Advisors Award for its Innovative AI SolutionsNew TrialAssure LINK® AI 2.0 Medical Writing Technology Debuts to the Pharmaceutical Industry at the DIA Annual Conference in San DiegoTrialAssure Joins NVIDIA InceptionTrialAssure Launches Anonymize 3.0 Technology for an Improved Data and Document Anonymization User Experience in Pharma and Beyond 
2023 2 releases TrialAssure Announces AI Generative Text Partnership with Top Clinical Research Organization MMS on New Medical Writing InitiativeIntroducing Trusano: The New Standard in AI-Powered Data and Document Anonymization, Redaction, and Masking Software
2022 1 release TrialAssure Surpasses Milestone 30 Million Markups in its Pharmaceutical Document Anonymization Software
2021 9 releases TrialAssure 2021 Year in Review!TrialAssure LINK Wins Gold Globee® for HealthCare Technology Solution in the 2021 International Best in Business AwardsNew TrialAssure LINK Technology Saves Up to 4 Weeks from Plain Language Summary WritingTrialAssure’s Transparency Suite Named Data Solution of the Year for the Second Consecutive YearCertara Adopts TrialAssure ANONYMIZE Solution to Speed Life Science Industry Need to Meet Regulatory Requirements for Data SharingThis week in transparency news: February 12-26, 2021This week in transparency news: January 30 – February 12, 2021This week in transparency news: January 9 – January 29, 2021This week in transparency news: December 19, 2020 – January 8, 2021
2020 20 releases This week in transparency news: December 5 – December 18, 2020This week in transparency news: November 21 – December 4, 2020This week in transparency news: November 7 – November 20, 2020Latest Release of TrialAssure ANONYMIZE for Documents Saves up to 80 Percent of Effort in PDF Document Anonymization and Redaction for Regulated Pharmaceutical Industry DocumentsThis week in transparency news: May 30 – June 12, 2020This week in transparency news: May 16 – May 29, 2020This week in transparency news: May 2 – May 15, 2020This week in transparency news: April 18 – May 1, 2020This week in transparency news: April 4 – April 17, 2020FORMER GILEAD SCIENCES HEAD OF CLINICAL TRIAL DISCLOSURE AND DATA TRANSPARENCY JOINS MMS AND TRIALASSURE AS DIRECTOR OF GLOBAL TRANSPARENCY STRATEGY AND COMPLIANCETRIALASSURE TRANSPARENCY SUITE WINS DATA SOLUTION OF THE YEAR—HEALTHCARE IN THE 2020 DATA BREAKTHROUGH AWARDSAs Universities and Academic Institutions Face Unique Challenges in Reporting Clinical Trials, TrialAssure Responds by Offering Free Clinical Trial Transparency ToolThis week in transparency news: March 20 – April 3, 2020This week in transparency news: March 7 – March 19, 2020Committed to the health of your projects during COVID-19This week in transparency news: February 22 – March 6, 2020This week in transparency news: February 8 – February 21, 2020This week in transparency news: January 25 – February 7, 2020This week in transparency news: January 11 – January 24, 2020This week in transparency news: December 21 – January 10, 2020
2019 47 releases This week in transparency news: December 7 – 20, 2019This week in transparency news: November 16 – December 6, 2019This week in transparency news: November 2 – November 15, 2019TrialAssure Launches First-in-Class Document Anonymization Tool Using Machine Learning and Artificial Intelligence to Protect Patient DataThis week in transparency news: October 19 – November 1, 2019This week in transparency news: October 5 – October 18, 2019This week in transparency news: September 28 – October 4, 2019This week in transparency news: September 21 – September 27, 2019This week in transparency news: September 14 – September 20, 2019TrialAssure’s ANONYMIZE for Data Patient Data Anonymization Tool Built with Machine Learning is Now Publicly AvailableThis week in transparency news: September 7 – September 13, 2019This week in transparency news: August 31 – September 6, 2019This week in transparency news: August 24 – August 30, 2019This week in transparency news: August 17 – August 23, 2019This week in transparency news: August 10 – August 16, 2019This week in transparency news: August 3 – August 9, 2019This week in transparency news: July 27 – August 2, 2019This week in transparency news: July 13 – July 19, 2019This week in transparency news: June 29 – July 12, 2019This week in transparency news: June 22 – June 28, 2019This week in transparency news: June 15 – June 21, 2019This week in transparency news: June 8 – June 14, 2019This week in transparency news: June 1 – June 7, 2019This week in transparency news: May 25 – May 31, 2019This week in transparency news: May 18 – May 24, 2019This week in transparency news: May 11 – May 17, 2019This Week in Transparency News: May 4 – May 10, 2019This week in transparency news: April 27 – May 3, 2019This week in transparency news: April 20 – April 26, 2019This week in transparency news: April 13 – April 19, 2019TrialAssure Amplifies Clinical Trial Transparency Functionality with the Release of REGISTRY 2.5This week in transparency news: April 6 – April 12, 2019This week in transparency news: March 30 – April 5, 2019This week in transparency news: March 23 – March 29, 2019This week in transparency news: March 16 – March 22, 2019This week in transparency news: March 2 – March 15, 2019This week in transparency news: February 23 – March 1, 2019Groundbreaking Transparency Application that Anonymizes Patient Data in Clinical Trials Launched by TrialAssureThis week in transparency news: February 16 – February 22, 2019This week in transparency news: February 9 – February 15, 2019This week in transparency news: February 2 – February 8, 2019This week in transparency news: January 26 – February 1, 2019TrialAssure Creates Higher Education Discount Pricing Model for Clinical Trial Disclosure Reporting SoftwareThis week in transparency news: January 19-25, 2019This week in transparency news: January 12-18, 2019This week in transparency news: January 5-11, 2019This week in transparency news: December 22, 2018 – January 4, 2019
2018 22 releases This week in transparency news: December 15-21, 2018This week in transparency news: December 8-14, 2018This week in transparency news: November 17-30, 2018This week in transparency news: November 10-16, 2018This week in transparency news: November 3-9, 2018This week in transparency news: October 27 – November 2, 2018This week in transparency news: October 13-26, 2018This week in transparency news: September 29 – October 12, 2018This week in transparency news: September 15-28, 2018This week in transparency news: September 8-14, 2018CIO of TrialAssure accepted into Forbes Technology CouncilThis week in transparency news: August 25 – September 7, 2018This week in transparency: August 18 – August 24, 2018TrialAssure Partners with Otsuka Pharmaceutical to Provide Clinical Trial Disclosure Reporting System for Global PipelineThis week in transparency news: August 10 – August 17, 2018TrialAssure® Announces New Applications in its Product Pipeline to Build The Ultimate Transparency Suite™This week in transparency news: August 4 – August 9, 2018This week in transparency news: July 28 – August 3, 2018This week in transparency news: July 21 – July 27, 2018This week in transparency news: July 14 – July 20, 2018This week in transparency news: July 7 – July 13, 2018This week in transparency news: June 30 – July 6, 2018
2017 1 release Research Organizations Commit to Full Transparency

Ready to see it on your own studies?

Get a demo

Trusted by clinical development teams at sponsors and CROs

Transparent Thinking

Regulatory changes, before they bite

Deadlines, rule changes and practical guidance on clinical trial transparency, in your inbox. No noise.

Subscribe